Inventor · disambiguated record
Traian Sulea
Also filed as: SULEA TRAIAN
32 granted patents·12 pending applications·122 citations·filing 2003–2023
96Inventor score
Files withNAT RES COUNCIL CANADA19ADC THERAPEUTICS SA4ALETHIA BIOTHERAPEUTICS INC4TREMBLAY GILLES BERNARD3O'CONNOR-MCCOURT MAUREEN D2
Top patents by PatentIndex Score
44 records- 0193US8658135B2Antagonists of ligands and uses thereofO'CONNOR-MCCOURT MAUREEN D·Filed 2009·Granted Feb 25, 2014·36 cites·12 claims
- 0292US8734760B2Antagonists of ligands and uses thereofNAT RES COUNCIL CANADA·Filed 2012·Granted May 27, 2014·14 cites·21 claims
- 0392US8318135B2Antagonist of ligands and uses thereofO'CONNOR-MCCOURT MAUREEN D·Filed 2008·Granted Nov 27, 2012·21 cites·21 claims
- 0486US12391743B2TGF-β-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2021·Granted Aug 19, 2025·1 cites·14 claims
- 0585US9393302B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·20 claims
- 0685US8937163B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofTREMBLAY GILLES BERNARD·Filed 2012·Granted Jan 20, 2015·6 cites·20 claims
- 0784US9828426B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 0883US8574548B2Antagonists of ligands and uses thereofCA NAT RESEARCH COUNCIL·Filed 2012·Granted Nov 5, 2013·4 cites·21 claims
- 0982US11091523B2Engineered TGF-β monomers and their use for inhibiting TGF-β signalingUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2017·Granted Aug 17, 2021·2 cites·23 claims
- 1082US10906973B2Antibody variants transmigrating the blood-brain barrier and uses thereofNAT RES COUNCIL CANADA·Filed 2017·Granted Feb 2, 2021·3 cites·19 claims
- 1181US8802826B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeTREMBLAY GILLES BERNARD·Filed 2010·Granted Aug 12, 2014·4 cites·14 claims
- 1280US10738115B2Humanized antibodies transmigrating the blood-brain barrier and uses thereofNAT RES COUNCIL CANADA·Filed 2017·Granted Aug 11, 2020·2 cites·14 claims
- 1379US10106614B2Insulin-like growth factor 1 receptor-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2014·Granted Oct 23, 2018·5 cites·11 claims
- 1478US8987417B2Covalently dimerized bivalent binding agentsZWAAGSTRA JOHN C·Filed 2011·Granted Mar 24, 2015·6 cites·8 claims
- 1577US10112998B2Insulin-like growth factor 1 receptor-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2014·Granted Oct 30, 2018·4 cites·11 claims
- 1676US9493562B2Anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 15, 2016·3 cites·14 claims
- 1774US9855291B2Anti-kidney associated antigen 1 (KAAG1) antibodiesTREMBLAY GILLES BERNARD·Filed 2009·Granted Jan 2, 2018·1 cites·14 claims
- 1874US2021054067A1Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 1972US2024101641A1Tgf-b-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2023·Application pending·0 cites
- 2069US10100117B2Insulin-like growth factor 1 receptor-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2014·Granted Oct 16, 2018·1 cites·11 claims
- 2164US12428460B2Engineered TGF-beta monomers and their use for inhibiting TGF-beta signalingUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2021·Granted Sep 30, 2025·0 cites·19 claims
- 2262US10597450B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2017·Granted Mar 24, 2020·0 cites·70 claims
- 2362US9512211B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·0 cites·8 claims
- 2461US10208129B2Antibodies selective for cells presenting ErbB2 at high densityTIKHOMIROV ILIA ALEXANDRE·Filed 2011·Granted Feb 19, 2019·1 cites·12 claims
- 2559US11866481B2TGF-β-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2018·Granted Jan 9, 2024·0 cites·43 claims
- 2658US2024301381A1Ace2-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 2755US12084510B2Antibodies selective for cells presenting EGFR at high densityGILEAD SCIENCES INC·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 2855US2018369269A1Antibodies that specifically block the biological activity of a tumor antigenADC THERAPEUTICS SA·Filed 2017·Application pending·0 cites
- 2953US12392777B2Antibody variants with pH-dependent antigen binding for selective targeting of solid tumorsNAT RES COUNCIL CANADA·Filed 2020·Granted Aug 19, 2025·0 cites·20 claims
- 3053US2004042961A1Development of an in vivo functional assay for proteasesFiled 2003·Application pending·0 cites
- 3153US2024408249A1Egfrviii-targeted compounds and uses thereofNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 3252US2017233487A1Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor VolumeALETHIA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3352US2022089704A1Humanized and stabilized fc5 variants for enhancement of blood brain barrier transportBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 3452US2019194349A1Antibodies selective for cells presenting erbb2 at high densityNAT RES COUNCIL CANADA·Filed 2018·Application pending·0 cites
- 3551US11591408B2Antibody glycoconjugates and methods of production and useNAT RES COUNCIL CANADA·Filed 2018·Granted Feb 28, 2023·0 cites·19 claims
- 3648US2024400697A1Humanized anti-egfr viii antibodies and antigen-binding fragments thereofNAT RES COUNCIL CANADA·Filed 2021·Application pending·0 cites
- 3745US10538575B2Soluble IGF receptor Fc fusion proteins and uses thereofTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV·Filed 2012·Granted Jan 21, 2020·0 cites·13 claims
- 3844US2020231652A1Tgf-b-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2016·Application pending·0 cites
- 3943US12421308B2Anti-G-CSF antibodies and uses thereofME THERAPEUTICS INC·Filed 2018·Granted Sep 23, 2025·0 cites·5 claims
- 4043US11384141B2Serum albumin binding antibodies for tuneable half-life extension of biologicsNAT RES COUNCIL CANADA·Filed 2019·Granted Jul 12, 2022·0 cites·20 claims
- 4142US11359010B2Humanized anti-S100A9 antibody and uses thereofUNIV LAVAL·Filed 2016·Granted Jun 14, 2022·0 cites·7 claims
- 4241US11945858B2Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indicationsNAT RES COUNCIL CANADA·Filed 2019·Granted Apr 2, 2024·0 cites·18 claims
- 4340US2021171613A1Clostridium difficile-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2018·Application pending·0 cites
- 4438US10570211B2Antibodies selective for cells presenting EGFR at high densityTIKHOMIROV ILIA ALEXANDRE·Filed 2012·Granted Feb 25, 2020·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Traian Sulea files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →